FDA-approved gene therapy invented at Nationwide Children’s carries a $3.2M price tag. Here’s why.

On Wednesday, a 5-year-old boy in Washington, D.C., received the first infusion with FDA-approved Elevidys, a gene therapy invented at Nationwide Children's Hospital for Duchenne muscular dystrophy, which usually kills by age 30.